The Difference in Neutrophil-Lymphocyte Ratio (NLR), Platelet-Lymphocyte Ratio (PLR), and Lactate Levels Between Sepsis and Septic Shock Patients Who Died in The ICU
Downloads
Introduction: Sepsis and septic shock are organ dysfunctions caused by the dysregulation of the body's response to infection and are the most common causes of death. Objective: This study aims to describe the neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and lactate levels in patients with sepsis and septic shock who died in the Intensive Care Unit (ICU). Methods: An observational retrospective study was conducted by examining the medical record data of sepsis and sepsis shock patients who were hospitalized in the ICU of Dr. Soetomo General Academic Hospital Surabaya from January to December 2019. Results: The study sample was 28 patients: 16 with sepsis and 12 with septic shock. Fifteen patients (53.6%) were women. The patients' mean age was 53.18 ± 13.61 years, and most patients (8 patients, 28.6%) belonged to the late adult age group (36-45 years). The most common comorbidities were diabetes mellitus and hypertension (30.8%). The highest incidence of infection in both groups occurred in the lungs (42.9%). Most of the patients had high SOFA scores, in the moderate (7-9) to severe (≥ 10) category (39.3%). Almost all patients (82.1%) were treated for less than one week. The hematological examination within the first 24 hours showed a leukocyte value of 16,995 (Leukocytosis) and a platelet value of 279,500 (Normal). The NLR of septic shock patients (31.38±55.61) was higher than the NLR of sepsis patients (23.75±22.87). The PLR of septic shock patients (534.02±1000.67) was lower than the PLR of patients (802.93±1509.89). Lastly, the lactate levels in septic shock patients (3.84±1.99) were higher than in sepsis patients (1.97±1.06). Conclusion: There were no significant differences in the NLR and PLR values "‹"‹between sepsis and septic shock patients, but there were significant differences in their initial lactate levels.
Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis current estimates and limitations. Am J Respir Crit Care Med. 2016 Feb 1;193(3):259–72.
Afifah, I., & Sopiany HM. KEPUTUSAN MENTERI KESEHATAN REPUBLIK INDONESIA NOMOR HK.01.07/MENKES/342/2017 TENTANG PEDOMAN NASIONAL PELAYANAN KEDOKTERAN TATA LAKSANA SEPSIS DENGAN RAHMAT TUHAN YANG MAHA ESA MENTERI KESEHATAN REPUBLIK INDONESIA. kemkes.go.id. 2017;87(1,2):149–200.
Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA - J Am Med Assoc. 2016;315(8):801–10.
Lengkong WY, Iskandar A. GAMBARANPLATELET-TO-LYMPHOCYTE RATIO (PLR) PADA SEPSIS DAN SYOK SEPTIK. Vol. 4, CHMK HEALTH JOURNAL. 2020.
Hwang SY, Shin TG, Jo IJ, Jeon K, Suh GY, Lee TR, et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients. Am J Emerg Med. 2017 Feb 1;35(2):234–9.
Velissaris D, Pantzaris ND, Bountouris P, Gogos C. Correlation between neutrophil-to-lymphocyte ratio and severity scores in septic patients upon hospital admission. A series of 50 patients. Rom J Intern Med. 2018;56(3):153–7.
Shen Y, Huang X, Zhang W. Platelet-to-lymphocyte ratio as a prognostic predictor of mortality for sepsis: Interaction effect with disease severity - A retrospective study. BMJ Open. 2019 Jan 1;9(1).
Angele MK, Pratschke S, Hubbard WJ, Chaudry IH. Gender differences in sepsis: Cardiovascular and immunological aspects. Vol. 5, Virulence. Taylor and Francis Inc.; 2014. p. 12–9.
Kaukonen K-M, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic Inflammatory Response Syndrome Criteria in Defining Severe Sepsis. N Engl J Med. 2015;372(17):1629–38.
Sinapidis D, Kosmas V, Vittoros V, Koutelidakis IM, Pantazi A, Stefos A, et al. Progression into sepsis: An individualized process varying by the interaction of comorbidities with the underlying infection. BMC Infect Dis. 2018 May 29;18(1).
Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, Kurosawa S, Stepien D, Valentine C, et al. Sepsis: Multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev. 2013;93(3):1247–88.
Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4–11.
Pavon A, Binquet C, Kara F, Martinet O, Ganster F, Navellou JC, et al. Profile of the risk of death after septic shock in the present era: An epidemiologic study. Crit Care Med. 2013;41(11):2600–9.
Baig MA, Sheikh S, Hussain E, Bakhtawar S, Subhan Khan M, Mujtaba S, et al. Comparison of qSOFA and SOFA score for predicting mortality in severe sepsis and septic shock patients in the emergency department of a low middle income country. Turkish J Emerg Med [Internet]. 2018;18(4):148–51. Available from: https://doi.org/10.1016/j.tjem.2018.08.002
Tu Y-P, Jennings R, Hart B, Cangelosi GA, Wood RC, Wehber K, et al. ce pt us cr ip t Ac ce pt us cr. Journals Gerontol Ser A Biol Sci Med Sci. 2018;0813(April):1–11.
Hatman FA. Risk Factor Analysis of Length of Stay In Sepsis Patients Who Died in. J "ŽAnestesiologi "ŽIndonesia. 2020;
Jarczak D, Kluge S, Nierhaus A. Sepsis”Pathophysiology and Therapeutic Concepts. Front Med. 2021;8(May):1–22.
Lekkou A, Mouzaki A, Siagris D, Ravani I, Gogos CA. Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis. J Crit Care. 2014;29(5):723–7.
Rajaee A, Barnett R, Cheadle WG. Pathogen- A nd Danger-Associated Molecular Patterns and the Cytokine Response in Sepsis. Surg Infect (Larchmt). 2018 Feb 1;19(2):107–16.
Jekarl DW, Kim KS, Lee S, Kim M, Kim Y. Cytokine and molecular networks in sepsis cases: a network biology approach. Eur Cytokine Netw. 2018 Sep 1;29(3):103–11.
Ryoo SM, Lee J, Lee YS, Lee JH, Lim KS, Huh JW, et al. Lactate Level Versus Lactate Clearance for Predicting Mortality in Patients with Septic Shock Defined by Sepsis-3. Crit Care Med. 2018;46(6):E489–95.
Nolt B, Tu F, Wang X, Ha T, Winter R, Williams DL, et al. Lactate and Immunosuppression in Sepsis. Vol. 49, Shock. Lippincott Williams and Wilkins; 2018. p. 120–5.
Garcia-Alvarez M, Marik P, Bellomo R. Sepsis-associated hyperlactatemia. Vol. 18, Critical Care. BioMed Central Ltd.; 2014.
Casserly B, Phillips GS, Schorr C, Dellinger RP, Townsend SR, Osborn TM, et al. Lactate measurements in sepsis-induced tissue hypoperfusion: Results from the surviving sepsis campaign database. Crit Care Med. 2015;43(3):567–73.
Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Vol. 44, Intensive Care Medicine. Springer Verlag; 2018. p. 925–8.
Copyright (c) 2023 Dwi Rachmawati, Arie Utariani, Paulus Budiono Notopuro, Bambang Pujo Semedi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Indonesian Journal of Anesthesiology and Reanimation (IJAR) licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. Copyright holder is the author.
2. The journal allows the author to share (copy and redistribute) and adapt (remix, transform, and build) upon the works under license without restrictions.
3. The journal allows the author to retain publishing rights without restrictions.
4. The changed works must be available under the same, similar, or compatible license as the original.
5. The journal is not responsible for copyright violations against the requirement as mentioned above.